Promino Nutritional Sciences Inc.
MUSLF
$0.044
-$0.0002-0.45%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -38.45% | -90.33% | -69.09% | 163.19% | -64.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -38.45% | -90.33% | -69.09% | 163.19% | -64.31% |
| Cost of Revenue | -91.79% | -55.58% | -102.11% | -53.53% | 49.60% |
| Gross Profit | 107.75% | -123.61% | -56.28% | 60.55% | -3,137.27% |
| SG&A Expenses | 294.65% | 207.68% | 241.73% | 22.32% | -133.41% |
| Depreciation & Amortization | -- | -- | -- | -25.00% | -15.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5,787.26% | 191.28% | 231.29% | -8.85% | -101.00% |
| Operating Income | -857.84% | -227.74% | -255.12% | 13.04% | 108.47% |
| Income Before Tax | -1,086.15% | -155.82% | -219.50% | 18.56% | 106.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,086.15% | -155.82% | -219.50% | 18.56% | 106.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,086.15% | -155.82% | -219.50% | 18.56% | 106.91% |
| EBIT | -857.84% | -227.74% | -255.12% | 13.04% | 108.47% |
| EBITDA | -837.16% | -229.27% | -256.89% | 13.01% | 108.70% |
| EPS Basic | -1,225.00% | -49.03% | -95.83% | 8.92% | 102.25% |
| Normalized Basic EPS | -1,314.29% | -48.84% | -95.56% | -5.56% | 102.10% |
| EPS Diluted | -1,225.00% | -49.03% | -95.83% | 8.92% | 102.25% |
| Normalized Diluted EPS | -1,314.29% | -48.84% | -95.56% | -5.56% | 102.10% |
| Average Basic Shares Outstanding | -12.99% | 71.62% | 62.80% | -10.62% | 207.96% |
| Average Diluted Shares Outstanding | -12.99% | 71.62% | 62.80% | -10.62% | 207.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
